{"id":"https://openalex.org/W2140959461","doi":"https://doi.org/10.18553/jmcp.2009.15.8.648","title":"Association of Prescription Abandonment with Cost Share for High-Cost Specialty Pharmacy Medications","display_name":"Association of Prescription Abandonment with Cost Share for High-Cost Specialty Pharmacy Medications","publication_year":2009,"publication_date":"2009-10-01","ids":{"openalex":"https://openalex.org/W2140959461","doi":"https://doi.org/10.18553/jmcp.2009.15.8.648","mag":"2140959461","pmid":"https://pubmed.ncbi.nlm.nih.gov/19803554","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10441203"},"language":"en","primary_location":{"id":"doi:10.18553/jmcp.2009.15.8.648","doi":"https://doi.org/10.18553/jmcp.2009.15.8.648","is_oa":true,"landing_page_url":"https://doi.org/10.18553/jmcp.2009.15.8.648","pdf_url":"https://www.jmcp.org/doi/epdf/10.18553/jmcp.2009.15.8.648?role=tab","source":{"id":"https://openalex.org/S40961437","display_name":"Journal of Managed Care Pharmacy","issn_l":"1083-4087","issn":["1083-4087","1944-706X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":"https://openalex.org/P4363609268","host_organization_name":"Academy of Managed Care Pharmacy","host_organization_lineage":["https://openalex.org/P4363609268"],"host_organization_lineage_names":["Academy of Managed Care Pharmacy"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Managed Care Pharmacy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jmcp.org/doi/epdf/10.18553/jmcp.2009.15.8.648?role=tab","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113657603","display_name":"Patrick P. Gleason","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick Gleason","raw_affiliation_strings":["Prime Therapeutics, 1305 Corporate Center Dr., Eagan, MN 55121, USA. pgleason@primetherapeutics.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prime Therapeutics, 1305 Corporate Center Dr., Eagan, MN 55121, USA. pgleason@primetherapeutics.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029134579","display_name":"Catherine I. Starner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine I. Starner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040562940","display_name":"Brent W. Gunderson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brent W. Gunderson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014236936","display_name":"Jeremy A Schafer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeremy A. Schafer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5039697453","display_name":"H. Scott Sarran","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Scott Sarran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":11.667,"has_fulltext":true,"cited_by_count":84,"citation_normalized_percentile":{"value":0.98182639,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":99},"biblio":{"volume":"15","issue":"8","first_page":"648","last_page":"658"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.6523000001907349,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.6523000001907349,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.12520000338554382,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.09619999676942825,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/specialty-medications","display_name":"specialty medications","score":0.8169999718666077},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.8790000081062317},{"id":"https://openalex.org/keywords/pharmacy-benefits","display_name":"pharmacy benefits","score":0.5059999823570251},{"id":"https://openalex.org/keywords/commercially-insured-patients","display_name":"commercially insured patients","score":0.6019999980926514},{"id":"https://openalex.org/keywords/medication-use","display_name":"medication use","score":0.39399999380111694}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8500146865844727},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.7979800701141357},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.6942876577377319},{"id":"https://openalex.org/C2779816988","wikidata":"https://www.wikidata.org/wiki/Q305418","display_name":"Abandonment (legal)","level":2,"score":0.6267160177230835},{"id":"https://openalex.org/C20387591","wikidata":"https://www.wikidata.org/wiki/Q930752","display_name":"Specialty","level":2,"score":0.6110674142837524},{"id":"https://openalex.org/C2776291444","wikidata":"https://www.wikidata.org/wiki/Q6806635","display_name":"Medicare Part D","level":4,"score":0.6103625297546387},{"id":"https://openalex.org/C100406419","wikidata":"https://www.wikidata.org/wiki/Q3543802","display_name":"Formulary","level":2,"score":0.5996321439743042},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.5589959621429443},{"id":"https://openalex.org/C2779848557","wikidata":"https://www.wikidata.org/wiki/Q317749","display_name":"Copayment","level":4,"score":0.5480225682258606},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.4469279646873474},{"id":"https://openalex.org/C2778858636","wikidata":"https://www.wikidata.org/wiki/Q1643563","display_name":"Prescription drug","level":3,"score":0.309222936630249},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.30273181200027466},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15332162380218506},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.1242516040802002},{"id":"https://openalex.org/C2983635472","wikidata":"https://www.wikidata.org/wiki/Q334911","display_name":"Health insurance","level":3,"score":0.07732829451560974},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007356","descriptor_name":"Insurance, Pharmaceutical Services","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016015","descriptor_name":"Logistic Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016312","descriptor_name":"Treatment Refusal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017047","descriptor_name":"Cost Sharing","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.18553/jmcp.2009.15.8.648","doi":"https://doi.org/10.18553/jmcp.2009.15.8.648","is_oa":true,"landing_page_url":"https://doi.org/10.18553/jmcp.2009.15.8.648","pdf_url":"https://www.jmcp.org/doi/epdf/10.18553/jmcp.2009.15.8.648?role=tab","source":{"id":"https://openalex.org/S40961437","display_name":"Journal of Managed Care Pharmacy","issn_l":"1083-4087","issn":["1083-4087","1944-706X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":"https://openalex.org/P4363609268","host_organization_name":"Academy of Managed Care Pharmacy","host_organization_lineage":["https://openalex.org/P4363609268"],"host_organization_lineage_names":["Academy of Managed Care Pharmacy"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Managed Care Pharmacy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10441203","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10441203","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10441203/pdf/jmcp.2009.15.8.648.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Manag Care Pharm","raw_type":"Text"},{"id":"pmid:19803554","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19803554","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of managed care pharmacy : JMCP","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.523.8837","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.523.8837","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://my.amcp.org/data/jmcp/648-658.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.18553/jmcp.2009.15.8.648","doi":"https://doi.org/10.18553/jmcp.2009.15.8.648","is_oa":true,"landing_page_url":"https://doi.org/10.18553/jmcp.2009.15.8.648","pdf_url":"https://www.jmcp.org/doi/epdf/10.18553/jmcp.2009.15.8.648?role=tab","source":{"id":"https://openalex.org/S40961437","display_name":"Journal of Managed Care Pharmacy","issn_l":"1083-4087","issn":["1083-4087","1944-706X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":"https://openalex.org/P4363609268","host_organization_name":"Academy of Managed Care Pharmacy","host_organization_lineage":["https://openalex.org/P4363609268"],"host_organization_lineage_names":["Academy of Managed Care Pharmacy"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Managed Care Pharmacy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320309636","display_name":"University of Minnesota","ror":"https://ror.org/03grvy078"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2140959461.pdf","grobid_xml":"https://content.openalex.org/works/W2140959461.grobid-xml"},"referenced_works_count":8,"referenced_works":["https://openalex.org/W28024029","https://openalex.org/W132980945","https://openalex.org/W2083585578","https://openalex.org/W2105984533","https://openalex.org/W2123499780","https://openalex.org/W2161685332","https://openalex.org/W2162084286","https://openalex.org/W2332063818"],"related_works":["https://openalex.org/W3024841348","https://openalex.org/W4414913193","https://openalex.org/W2109927828","https://openalex.org/W2472569094","https://openalex.org/W4367549049","https://openalex.org/W2063223428","https://openalex.org/W2778096494","https://openalex.org/W4255298899","https://openalex.org/W2972546353","https://openalex.org/W4240231069"],"abstract_inverted_index":{"BACKGROUND:":[0],"In":[1,429,545],"2008,":[2],"specialty":[3,42,166,311,625,699],"medications":[4],"accounted":[5],"for":[6,160,219,242,300,317,341,350,379,477,501,510,540,560,576,645,653],"15.1%":[7],"of":[8,32,55,91,96,147,198,205,253,274,337,347,360,389,397,444,453,498,507,520,572,587,591,596,621],"total":[9],"pharmacy":[10,64,157],"benefit":[11,65],"medication":[12,43,93,120,167,312,554,626,648,655],"spending,":[13],"and":[14,45,112,143,221,235,244,298,308,314,362,475,522,581,629,649,679,681,706,719],"per":[15,260,638,677],"member":[16,50,74,232,707],"expenditures":[17,44],"have":[18,79,703],"increased":[19,374,377,534,538,659],"by":[20,101],"11.1%":[21],"annually":[22],"from":[23,171],"2004":[24],"to":[25,40,46,152,227,329,446,490,574,616,687,715],"2008":[26],"within":[27,60],"a":[28,56,97,102,123,141,156,161,206,327,342,351,488,502,511,618,669],"commercially":[29,149],"insured":[30,150],"population":[31],"8":[33],"million":[34],"members.":[35],"Insurers":[36],"face":[37],"increasing":[38,49],"pressure":[39],"control":[41],"rely":[47],"on":[48,70,80,704],"cost":[51],"share":[52],"through":[53,174],"creation":[54],"fourth":[57],"copayment":[58],"tier":[59],"the":[61,71,85,92,107,169,199,213,229,239,254,291,295,318,338,348,409,430,435,508,546,551,613,682,696,721],"incentive-based":[62],"formulary":[63,303],"system.":[66],"Data":[67],"are":[68],"needed":[69],"influence":[72],"that":[73,637,692,698],"out-of-pocket":[75],"(OOP)":[76],"expense":[77,114,234,258,283,359,367,388,404,452,479,519,527,537,563,578,586,595,628,674,701],"may":[78,702],"prescription":[81,99,110,328,489,632,660,726],"abandonment":[82,111,178,193,236,279,372,395,410,436,532,555,569,592],"(defined":[83],"as":[84,196,294,375,535],"patient":[86],"never":[87],"actually":[88],"taking":[89],"possession":[90],"despite":[94],"evidence":[95,204],"written":[98],"generated":[100],"prescriber).":[103],"OBJECTIVE:":[104],"To":[105],"explore":[106],"relationship":[108,671],"between":[109,231,473,579,624,672],"OOP":[113,233,257,282,293,358,366,376,387,403,442,451,478,518,526,536,562,577,585,594,627,640,673,689,700],"among":[115,181],"individuals":[116,151],"newly":[117,185,330,491],"initiating":[118,186],"high-cost":[119,332],"therapy":[121,224,631],"with":[122,155,202,281,286,345,385,415,449,505,568,584,658,665,725],"tumor":[124],"necrosis":[125],"factor":[126],"(TNF)":[127],"blocker":[128,163,188,223,278,320,494,553,647],"or":[129,164,189,268,276,391,455],"multiple":[130],"sclerosis":[131],"(MS)":[132],"biologic":[133],"agent.":[134],"METHODS:":[135],"This":[136,611],"observational":[137],"cross-sectional":[138],"study":[139,615,635],"queried":[140],"midwestern":[142],"southern":[144],"U.S.":[145],"database":[146],"13,172,480":[148],"find":[153],"members":[154,184,325,400,421,486],"benefit-adjudicated":[158],"claim":[159,201,211,639],"TNF":[162,187,222,277,319,493,552,646],"MS":[165,190,220,275,333,424,654],"during":[168],"period":[170],"July":[172],"2006":[173],"June":[175],"2008.":[176],"Prescription":[177,192],"was":[179,194,284,412,557],"assessed":[180],"continuously":[182],"enrolled":[183],"therapy.":[191],"defined":[195],"reversal":[197],"adjudicated":[200,209],"no":[203],"subsequent":[207],"additional":[208],"paid":[210],"in":[212,401,419],"ensuing":[214],"90":[215],"days.":[216],"Separate":[217],"analyses":[218],"were":[225,249,340,500,600,656],"performed":[226,714],"assess":[228,720],"association":[230,273,623],"rate":[237,280,373,396,411,437,533,556],"using":[238,290],"Cochran-Armitage":[240],"test":[241],"trend":[243],"multivariate":[245,431,547],"logistic":[246,287,432,548],"regression.":[247],"Members":[248,384],"placed":[250],"into":[251],"1":[252,418],"7":[255],"following":[256],"groups":[259,405,480,564],"claim:":[261],"$0-$100,":[262,361],"$101-$150,":[263],"$151-$200,":[264],"$201-$250,":[265],"$251-$350,":[266],"$351-$500,":[267],"more":[269,416],"than":[270,369,407,417,482,529,566,598,643,651],"$500.":[271,370,530],"The":[272,371,469,531,589,634],"tested":[285],"regression":[288,433,549],"models":[289],"$0-$100":[292,521],"reference":[296],"group":[297],"adjusting":[299],"age,":[301],"gender,":[302],"status,":[304],"ZIP":[305],"code-level":[306],"income":[307],"education,":[309],"earliest":[310],"claim,":[313],"methotrexate":[315],"use":[316],"analysis.":[321],"RESULTS:":[322],"Of":[323,484],"2,791":[324],"presenting":[326,487],"initiate":[331,492],"therapy,":[334,495],"1,985":[335],"(71.1%)":[336],"claims":[339,425,499],"1-month":[343,503],"supply":[344,504],"most":[346,506],"remainder":[349,509],"3-month":[352,512],"supply;":[353,513],"2,303":[354],"(82.5%)":[355],"had":[356,364,393,516,524],"an":[357,365,386,394,450,517,525,622],"5.4%":[363],"greater":[368,406,481,528,565,597,642,650],"(test":[378,539],"trend,":[380,541],"P":[381,542],"<":[382,427,543],"0.001).":[383,428,544],"$100":[390,454,644,676],"less":[392,456],"5.7%.":[398],"Among":[399],"all":[402,561],"$200,":[408],"significantly":[413,439,558],"higher,":[414],"4":[420],"abandoning":[422],"their":[423],"(P":[426],"analysis,":[434,550],"became":[438],"higher":[440,559,602],"at":[441,593],"expenses":[443,641],"$201":[445],"$250":[447],"compared":[448,583],"(odds":[457],"ratio":[458],"[OR]":[459],"=":[460,466,604,608],"7.3,":[461],"95%":[462,606],"confidence":[463],"interval":[464],"[CI]":[465],"3.3-":[467],"16.2).":[468],"odds":[470,570,590],"ratios":[471,571],"ranged":[472],"6.1":[474],"7.3":[476],"$200.":[483],"7,313":[485],"5,809":[496],"(79.4%)":[497],"6,123":[514],"(83.7%)":[515],"5.7%":[523],"$100,":[567],"2.3":[573],"4.4":[575],"$101":[580],"$500":[582,599],"$0-$100.":[588],"7-fold":[601],"(OR":[603],"7.0,":[605],"CI":[607],"5.4-9.1).":[609],"CONCLUSIONS:":[610],"is":[612],"first":[614],"perform":[617],"focused":[619],"assessment":[620],"new":[630],"abandonment.":[633,661,727],"found":[636],"$200":[652],"associated":[657,724],"These":[662],"findings":[663,718],"coupled":[664],"previous":[666],"research":[667,711],"identifying":[668],"negative":[670],"above":[675],"month":[678],"adherence,":[680],"commercial":[683],"insurance":[684],"market":[685],"response":[686],"fourth-tier":[688],"expenses,":[690],"suggests":[691],"insurers":[693],"should":[694,712],"consider":[695],"impact":[697],"adherence":[705],"satisfaction.":[708],"Further":[709],"prospective":[710],"be":[713],"confirm":[716],"these":[717],"clinical":[722],"outcomes":[723]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}